Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Innoviva (INVA)

Innoviva: Directors Derek Small and Mark DiPaolo resign; Josephine Linden joins board

Neutral Impact 2 of 5 leadership Written later

Innoviva directors Derek Small and Mark DiPaolo resigned on May 12, 2026, to focus on Syndeio BioSciences, where Small is CEO and DiPaolo is expected to take an executive role. On May 18, 2026, the board elected Josephine Linden as a director, and she is expected to serve on the Audit Committee. The filing describes the resignations as unrelated to any disagreement with the company, and the change is a board composition update rather than a financial result.

Key points

  • Derek Small and Mark DiPaolo resigned from the board on May 12, 2026, to focus on Syndeio BioSciences Inc.
  • Josephine Linden was elected to the board on May 18, 2026; the board has determined she is independent.
  • Linden is expected to serve on the Audit Committee and will receive a $125,000 initial RSU award plus prorated annual awards of $206,250 in RSUs and options on 9,166 shares.

The filing

CompanyInnoviva (INVA)
Form8-K, current report
Filed with the SECMay 18, 2026, 4:21 PM ET
Accession number0001193125-26-228958

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 18, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.